BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Totonchy M, Leffell D. Emerging concepts and recent advances in basal cell carcinoma. F1000Res 2017;6:2085. [PMID: 29259776 DOI: 10.12688/f1000research.11314.1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Woltsche N, Pichler N, Wolf I, Di Meo N, Zalaudek I. Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single centre experience. J Eur Acad Dermatol Venereol 2018;33. [DOI: 10.1111/jdv.15367] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
2 Li Y, Li Y, Li L. Circular RNA hsa_Circ_0005795 mediates cell proliferation of cutaneous basal cell carcinoma via sponging miR-1231. Arch Dermatol Res 2021. [PMID: 33433717 DOI: 10.1007/s00403-020-02174-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Vornicescu C, Șenilă SC, Bejinariu NI, Vesa ȘC, Boșca AB, Chirilă DN, Melincovici CS, Sorițău O, Mihu CM. Predictive factors for the recurrence of surgically excised basal cell carcinomas: A retrospective clinical and immunopathological pilot study. Exp Ther Med 2021;22:1336. [PMID: 34630690 DOI: 10.3892/etm.2021.10771] [Reference Citation Analysis]
4 Chow M, Moon D, Mosallaei D, Trodello C, Higgins S, Hu J, Wysong A. The Importance of Completely Removing Basal Cell Carcinoma at First Presentation. Dermatol Surg 2020;46:416-8. [PMID: 31246875 DOI: 10.1097/DSS.0000000000002008] [Reference Citation Analysis]
5 Russo F, Mancini V, Trovato E, Fimiani M, Taddeucci P. BCC and vismodegib: can we treat and remold at the same time? G Ital Dermatol Venereol 2020;155:119-20. [PMID: 29781264 DOI: 10.23736/S0392-0488.18.06043-1] [Reference Citation Analysis]
6 Peters M, Smith JD, Kovatch KJ, McLean S, Durham AB, Basura G. Treatment and Outcomes for Cutaneous Periauricular Basal Cell Carcinoma: A 16-Year Institutional Experience. OTO Open 2020;4:2473974X20964735. [PMID: 33150296 DOI: 10.1177/2473974X20964735] [Reference Citation Analysis]